Stephan Ludwig

Q: What Schools Are Affiliated With Stephan Ludwig

Stephan Ludwig is affiliated with the following schools: University of California, Berkeley, Stanford University, University of Würzburg, University of Münster

Stephan Ludwig's AcademicInfluence.com Rankings

Stephan Ludwig

Computer Science

#10001

World Rank

#10492

Historical Rank

Computational Linguistics

#2496

World Rank

#2521

Historical Rank

Machine Learning

#4524

World Rank

#4575

Historical Rank

Artificial Intelligence

#4882

World Rank

#4946

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Stephan Ludwig's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Stephan Ludwig Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephan Ludwig's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock (2007) (1272)
Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade (2001) (503)
Caspase 3 activation is essential for efficient influenza virus propagation (2003) (336)
IFN‐α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling‐3 (2003) (334)
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. (2004) (318)
Influenza A Virus NS1 Protein Activates the PI3K/Akt Pathway To Mediate Antiapoptotic Signaling Responses (2007) (307)
The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells (2010) (282)
Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression (2008) (271)
NF-κB-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation* (2004) (252)
The Stress Inducer Arsenite Activates Mitogen-activated Protein Kinases Extracellular Signal-regulated Kinases 1 and 2 via a MAPK Kinase 6/p38-dependent Pathway* (1998) (230)
Bivalent role of the phosphatidylinositol‐3‐kinase (PI3K) during influenza virus infection and host cell defence (2006) (227)
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells (2006) (224)
The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors (2002) (199)
Coronaviruses and SARS-CoV-2: A Brief Overview (2020) (197)
Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. (2000) (196)
Activation of NF-κB via the IκB Kinase Complex Is Both Essential and Sufficient for Proinflammatory Gene Expression in Primary Endothelial Cells* (2001) (192)
3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways (1996) (190)
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF‐κB‐inhibiting activity (2007) (186)
Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. (2001) (178)
MAPKAP Kinase 3pK Phosphorylates and Regulates Chromatin Association of the Polycomb Group Protein Bmi1* (2005) (173)
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity (2020) (164)
Influenza-virus-induced signaling cascades: targets for antiviral therapy? (2003) (163)
The MKK6/p38 Stress Kinase Cascade Is Critical for Tumor Necrosis Factor-–Induced Expression of Monocyte-Chemoattractant Protein-1 in Endothelial Cells (1999) (158)
Polyethylenimine, a cost-effective transfection reagent (2006) (156)
A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway (2009) (155)
The proapoptotic influenza A virus protein PB1‐F2 regulates viral polymerase activity by interaction with the PB1 protein (2008) (153)
Influenza Virus-induced NF-κB-dependent Gene Expression Is Mediated by Overexpression of Viral Proteins and Involves Oxidative Radicals and Activation of IκB Kinase* (2000) (151)
Evolution of pig influenza viruses. (1991) (150)
A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. (2007) (146)
Membrane Accumulation of Influenza A Virus Hemagglutinin Triggers Nuclear Export of the Viral Genome via Protein Kinase Cα-mediated Activation of ERK Signaling* (2006) (137)
Erk5 Activation Elicits a Vasoprotective Endothelial Phenotype via Induction of Krüppel-like Factor 4 (KLF4)* (2010) (136)
Interplay between influenza A virus and the innate immune signaling. (2010) (128)
Transcriptional profiling of IKK2/NF-κB— and p38 MAP kinasedependent gene expression in TNF-α—stimulated primary human endothelial cells (2004) (128)
Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. (2015) (127)
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation (2018) (126)
Influenza Virus-induced AP-1-dependent Gene Expression Requires Activation of the JNK Signaling Pathway* (2001) (122)
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. (2009) (121)
Phylogenetic relationship of the nonstructural (NS) genes of influenza A viruses. (1991) (121)
CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. (2007) (121)
European swine virus as a possible source for the next influenza pandemic? (1995) (120)
Rac1 and PAK1 are upstream of IKK‐ε and TBK‐1 in the viral activation of interferon regulatory factor‐3 (2004) (120)
Different Mitogen-activated Protein Kinase Signaling Pathways Cooperate to Regulate Tumor Necrosis Factor α Gene Expression in T Lymphocytes* (1999) (118)
MEK inhibition impairs influenza B virus propagation without emergence of resistant variants (2004) (118)
Regulation of Suppressor of Cytokine Signaling 3 (SOCS3) mRNA Stability by TNF-α Involves Activation of the MKK6/p38MAPK/MK2 Cascade1 (2007) (116)
Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. (2001) (114)
The Mitogen-activated Protein (MAP) Kinase p38 and Its Upstream Activator MAP Kinase Kinase 6 Are Involved in the Activation of Signal Transducer and Activator of Transcription by Hyperosmolarity* (1999) (113)
MEK-Specific Inhibitor U0126 Blocks Spread of Borna Disease Virus in Cultured Cells (2001) (113)
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine (2020) (112)
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity (2021) (110)
Ras-independent Activation of the Raf/MEK/ERK Pathway upon Calcium-induced Differentiation of Keratinocytes* (2000) (109)
Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1 (2005) (109)
Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury (2012) (105)
Influenza viruses and the NF-κB signaling pathway – towards a novel concept of antiviral therapy (2008) (104)
Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs. (1997) (103)
Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. (2011) (99)
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. (2004) (97)
A Pandemic in Times of Global Tourism: Superspreading and Exportation of COVID-19 Cases from a Ski Area in Austria (2020) (94)
Essential Impact of NF-κB Signaling on the H5N1 Influenza A Virus-Induced Transcriptome1 (2009) (93)
Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection* (2013) (92)
Neurotrophin Receptor-interacting Mage Homologue Is an Inducible Inhibitor of Apoptosis Protein-interacting Protein That Augments Cell Death* (2001) (92)
PAR1 contributes to influenza A virus pathogenicity in mice. (2013) (88)
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. (2011) (83)
The NS Segment of an H5N1 Highly Pathogenic Avian Influenza Virus (HPAIV) Is Sufficient To Alter Replication Efficiency, Cell Tropism, and Host Range of an H7N1 HPAIV (2009) (82)
The influenza virus PB1-F2 protein has interferon antagonistic activity (2011) (81)
Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. (2009) (78)
Serine/Threonine Kinases 3pK and MAPK-activated Protein Kinase 2 Interact with the Basic Helix-Loop-Helix Transcription Factor E47 and Repress Its Transcriptional Activity* (2000) (77)
A new splice variant of the human guanylate‐binding protein 3 mediates anti‐influenza activity through inhibition of viral transcription and replication (2012) (76)
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections (2011) (74)
The Contact Allergen Nickel Triggers a Unique Inflammatory and Proangiogenic Gene Expression Pattern via Activation of NF-κB and Hypoxia-Inducible Factor-1α1 (2007) (72)
The MKK6/p38 Mitogen-Activated Protein Kinase Pathway Is Capable of Inducing SOCS3 Gene Expression and Inhibits IL-6-Induced Transcription (2001) (72)
Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. (2007) (71)
Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. (2004) (71)
Genetics, evolution, and the zoonotic capacity of European Swine influenza viruses. (2013) (70)
The NF‐κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance (2013) (69)
The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. (1999) (68)
Candida albicans Triggers Activation of Distinct Signaling Pathways to Establish a Proinflammatory Gene Expression Program in Primary Human Endothelial Cells1 (2007) (65)
A fatal relationship--influenza virus interactions with the host cell. (1999) (64)
Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. (2005) (64)
Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain (2015) (63)
Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina (2008) (63)
Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. (2012) (62)
Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection (2013) (61)
Activation of Cardiac c-Jun NH2-Terminal Kinases and p38-Mitogen-Activated Protein Kinases With Abrupt Changes in Hemodynamic Load (2001) (61)
The NS1 Protein of Influenza A Virus Blocks RIG-I-Mediated Activation of the Noncanonical NF-κB Pathway and p52/RelB-Dependent Gene Expression in Lung Epithelial Cells (2012) (61)
Combined Action of Influenza Virus and Staphylococcus aureus Panton–Valentine Leukocidin Provokes Severe Lung Epithelium Damage (2012) (60)
Phosphorylation of the influenza A virus protein PB1‐F2 by PKC is crucial for apoptosis promoting functions in monocytes (2009) (60)
Interleukin‐27 displays interferon‐γ–like functions in human hepatoma cells and hepatocytes (2009) (59)
Phosphatidylinositol‐3‐kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig‐I to promote efficient type I interferon production (2011) (57)
Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions (2014) (57)
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface (2020) (55)
H5N1 Virus Activates Signaling Pathways in Human Endothelial Cells Resulting in a Specific Imbalanced Inflammatory Response (2011) (55)
Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages (2005) (54)
Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. (2001) (54)
Differences in Cell Activation by Chlamydophila pneumoniae and Chlamydia trachomatis Infection in Human Endothelial Cells (2004) (52)
Recent influenza A (H1N1) infections of pigs and turkeys in northern Europe. (1994) (52)
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro (2021) (51)
Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells (2018) (51)
Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. (2001) (51)
β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling (2014) (50)
Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood‐derived macrophages (2012) (48)
CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK‐mediated apoptotic responses (2010) (48)
3-O-Galloylated Procyanidins from Rumex acetosa L. Inhibit the Attachment of Influenza A Virus (2014) (47)
Immunomodulatory Nonstructural Proteins of Influenza A Viruses. (2018) (46)
The Clinically Approved Proteasome Inhibitor PS-341 Efficiently Blocks Influenza A Virus and Vesicular Stomatitis Virus Propagation by Establishing an Antiviral State (2010) (46)
Interaction between S100A8/A9 and Annexin A6 Is Involved in the Calcium-induced Cell Surface Exposition of S100A8/A9* (2008) (45)
Activation of Phosphatidylinositol 3-Kinase Signaling by the Nonstructural NS1 Protein Is Not Conserved among Type A and B Influenza Viruses (2007) (44)
Annexin A6-Balanced Late Endosomal Cholesterol Controls Influenza A Replication and Propagation (2013) (43)
Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus (2018) (42)
Derivation of the nucleoproteins (NP) of influenza A viruses isolated from marine mammals. (1990) (42)
Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice (2004) (42)
Activation of NF-κB by IL-1β blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human γ-fibrinogen gene (2007) (41)
Origin of the 1918 pandemic H1N1 influenza A virus as studied by codon usage patterns and phylogenetic analysis. (2011) (41)
MEK5/ERK5 Signaling Modulates Endothelial Cell Migration and Focal Contact Turnover (2009) (40)
Macrophage‐mediated psoriasis can be suppressed by regulatory T lymphocytes (2016) (39)
Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses (2012) (39)
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo (2019) (38)
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo. (2017) (38)
Super‐infection with Staphylococcus aureus inhibits influenza virus‐induced type I IFN signalling through impaired STAT1‐STAT2 dimerization (2015) (36)
Deficiency in the LIM‐only protein FHL2 impairs assembly of extracellular matrix proteins (2008) (36)
The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model (2019) (35)
The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. (2013) (35)
Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. (2007) (35)
The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression (2018) (34)
Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-kappa b activity. (2001) (33)
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity (2009) (33)
Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity (2016) (32)
Interaction of influenza A virus matrix protein with RACK1 is required for virus release (2012) (32)
A reassortant H1N1 influenza A virus caused fatal epizootics among camels in Mongolia. (1993) (32)
Borna Disease Virus Nucleoprotein Interacts with the Cdc2-Cyclin B1 Complex (2003) (31)
Dual Function of Interleukin-1β for the Regulation of Interleukin-6-induced Suppressor of Cytokine Signaling 3 Expression* (2004) (31)
Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection (2017) (30)
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro (2021) (30)
A Plant Extract of Ribes nigrum folium Possesses Anti-Influenza Virus Activity In Vitro and In Vivo by Preventing Virus Entry to Host Cells (2013) (29)
Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. (2001) (29)
New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant. (2014) (29)
Activation of c-jun N-Terminal Kinase upon Influenza A Virus (IAV) Infection Is Independent of Pathogen-Related Receptors but Dependent on Amino Acid Sequence Variations of IAV NS1 (2014) (29)
Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells (2012) (29)
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro (2020) (28)
Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus. (2016) (28)
MAP kinase‐activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR (2010) (28)
A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice. (2012) (27)
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways. (2002) (27)
The Rac1 Inhibitor NSC23766 Exerts Anti-Influenza Virus Properties by Affecting the Viral Polymerase Complex Activity (2014) (25)
Selective expression of calcium-binding proteins S100a8 and S100a9 at distinct sites of hair follicles. (2001) (25)
The binding of Mss4 to α‐integrin subunits regulates matrix metalloproteinase activation and fibronectin remodeling (2007) (25)
Agonists of Proteinase-Activated Receptor-2 Enhance IFN-γ-Inducible Effects on Human Monocytes: Role in Influenza A Infection1 (2008) (25)
Identification and characterisation of novel Mss4-binding Rab GTPases (2011) (24)
Influenza, a One Health paradigm--novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential. (2014) (24)
Mitogen-activated 3p kinase is active in the nucleus. (2004) (24)
The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis (2013) (23)
Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo (2013) (23)
Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549 (2016) (23)
Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability (2016) (23)
Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein (2015) (23)
In Vitro and In Vivo Antitumor Activity of a Novel Semisynthetic Derivative of Cucurbitacin B (2015) (22)
Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients (2018) (22)
Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages (2018) (21)
Influenza viruses and MAP kinase cascades – Novel targets for an antiviral intervention? (2007) (21)
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics (2021) (20)
Targeting a metabolic pathway to fight the flu (2017) (20)
Doxycycline-Induced Expression of Transgenic Human Tumor Necrosis Factor α in Adult Mice Results in Psoriasis-like Arthritis (2013) (20)
Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways (2017) (19)
Transactivation of Naturally Occurring HIV-1 Long Terminal Repeats by the JNK Signaling Pathway (2000) (19)
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities (2019) (19)
Constitutive Activation of the Transcription Factor NF-κB Results in Impaired Borna Disease Virus Replication (2005) (18)
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development (2021) (18)
Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug (2017) (18)
The influenza A virus matrix protein as a marker to monitor initial virus internalisation (2009) (18)
Late activation of the Raf/MEK/ERK pathway is required for translocation of the respiratory syncytial virus F protein to the plasma membrane and efficient viral replication (2018) (17)
Antiviral efficacy against Influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model. (2020) (16)
Exploited defense: how influenza viruses take advantage of antiviral signaling responses (2007) (16)
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses (2022) (16)
Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection (2020) (16)
SARS-CoV-2 Quasispecies Mediate Rapid Virus Evolution and Adaptation (2020) (15)
Caspase Inhibition Activates HIV in Latently Infected Cells (2002) (15)
Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95‐stimulated T lymphocytes (2002) (15)
Influenza A virus TRIMs the type I interferon response. (2009) (15)
Previous H1N1 influenza A viruses circulating in the Mongolian population (2005) (14)
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases (2020) (14)
Avian influenza viruses inhibit the major cellular signalling integrator c‐Abl (2014) (14)
Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes (2020) (14)
Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy (2017) (14)
Amino acid replacements leading to temperature-sensitive defects of the NS1 protein of influenza A virus (2005) (13)
Cascading towards vascular disorder gene therapy (1995) (13)
The adaptor protein FHL2 enhances the cellular innate immune response to influenza A virus infection (2012) (13)
Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound (2018) (13)
The human H3N2 influenza viruses A/Victoria/3/75 and A/Hiroshima/52/2005 preferentially bind to α2-3-sialylated monosialogangliosides with fucosylated poly-N-acetyllactosaminyl chains. (2012) (13)
Mss4 protein is a regulator of stress response and apoptosis (2012) (13)
The Vesicular Stomatitis Virus Matrix Protein Inhibits Glycoprotein 130-Dependent STAT Activation1 (2001) (12)
MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling (2019) (12)
Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic? (2015) (12)
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection (2022) (12)
Role of proteinase‐activated receptor‐2 in anti‐bacterial and immunomodulatory effects of interferon‐γ on human neutrophils and monocytes (2011) (12)
Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine. (2012) (12)
Proteinase-Activated Receptor-2 Agonist Activates Anti-Influenza Mechanisms and Modulates IFNγ-Induced Antiviral Pathways in Human Neutrophils (2013) (11)
Influenza A virus NS1 protein‐induced JNK activation and apoptosis are not functionally linked (2017) (11)
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2 (2022) (11)
MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T‐cell development upon influenza A virus infection (2014) (11)
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages (2022) (10)
Staphylococcus aureus triggers a shift from influenza virus–induced apoptosis to necrotic cell death (2018) (10)
Tumour Necrosis Factor-α Promoter Polymorphism in Erythema Nodosum (2001) (10)
Inhibition of p 38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H 5 N 1 infection (2017) (9)
Highly Pathogenic Influenza Viruses Inhibit Inflammatory Response in Monocytes via Activation of Rar-Related Orphan Receptor RORa (2013) (9)
FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis (2014) (9)
The first versatile human iPSC-based model of ectopic virus induction allows new insights in RNA-virus disease (2020) (9)
The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release. (2017) (8)
The Two Sides of the Same Coin-Influenza Virus and Intracellular Signal Transduction. (2019) (8)
Deficiency of Fhl2 leads to delayed neuronal cell migration and premature astrocyte differentiation (2019) (8)
SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids (2021) (7)
Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections (2021) (7)
The Four-and-a-Half LIM Domain Protein 2 Supports Influenza A Virus-Induced Lung Inflammation by Restricting the Host Adaptive Immune Response. (2018) (7)
Human Lungs Show Limited Permissiveness for SARS-CoV-2 Due to Scarce ACE2 Levels But Strong Virus-Induced Immune Activation in Alveolar Macrophages (2020) (7)
Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function (2021) (7)
Advances in Transgenic Mouse Models to Study Infections by Human Pathogenic Viruses (2020) (7)
Raf-dependent signaling pathways in cell growth and differentiation (1998) (6)
Will omics help to cure the flu? (2014) (5)
Proliferative Inhibition and Apoptotic Mechanism on Human Non-small-cell Lung Cancer (A549 Cells) of a Novel Cucurbitacin from Wilbrandia ebracteata Cogn (2013) (5)
Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets (2021) (5)
Type I interferon antagonistic properties of influenza B virus polymerase proteins (2019) (5)
, AP-1 Transcription Factors Activation of Jun N-Terminal Kinase and The Influenza A Virus NS 1 Protein Inhibits (2002) (5)
The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated with Specific Structures in the Nucleus (2021) (5)
The polyphenol rich plant extract CYSTUS052 is highly effective against H5N1 and pandemic H1N1v influenza A virus (2011) (5)
Transcriptional profiling of IKK 2 / NF-B – and p 38 MAP kinase – dependent gene expression in TNF-– stimulated primary human endothelial cells (2004) (5)
Caspase Inhibitors as a Supplement in Immune Activation Therapies to Achieve Eradication of HIV in Its Latent Reservoirs (2003) (5)
Monoclonal antibodies against the PB1-F2 protein of H1N1 influenza A virus. (2010) (4)
Gehäuftes Auftreten von Erkrankungen mit Salmonella Enteritidis in Krankenhäusern und Altenheimen im Landkreis Oberallgäu (Bayern) im Juli 2004 (2005) (4)
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs (2022) (4)
Short Communication Polyethylenimine, a cost-effective transfection reagent (2006) (4)
Relevance of Angiotensin-(1-7) and its receptor Mas in pneumonia caused by Influenza virus and post-influenza pneumococcal infection. (2020) (4)
PD-1 IC Inhibition Synergistically Improves Influenza A Virus-Mediated Oncolysis of Metastatic Pulmonary Melanoma (2020) (4)
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors (2021) (4)
Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers (2021) (4)
Antiadhäsive Eigenschaften der Pflanzenextrakte Cystus052 und Ladania067 als breit wirksames antivirales Prinzip gegen respiratorische Viren (2013) (4)
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections (2020) (3)
Der Pflanzenextrakt Cystus052 blockiert Grippeviren (2012) (3)
Borna Disease Virus Nucleoprotein Interacts with the Cdc 2-Cyclin B 1 Complex (2003) (3)
Semisynthetic Cardenolides Acting as Antiviral Inhibitors of Influenza A Virus Replication by Preventing Polymerase Complex Formation (2020) (3)
Cellular immune response in infected mice to NSP protein encoded by the negative strand NS RNA of influenza A virus (2019) (3)
Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice (2021) (3)
CYSTUS052, a Polyphenol Rich Plant Extract, Exerts Potent Antiviral Activity Against Influenza- and Rhinoviruses by Preventing Viral Attachment to Host Cells (2010) (3)
The German Research Platform for Zoonoses – One Health, One Research Community ☆ (2016) (3)
The NF-κB-Inhibitor SC75741 Efficiently Blocks Influenza Virus Propagation by Retention of the Viral RNP Complexes in the Nucleus without the Tendency to Induce Resistant Virus Variants (2010) (2)
Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection (2021) (2)
The epidermal growth factor receptor (EGFR) contributes to efficient entry of influenza A viruses into host cells (2009) (2)
Targeting the endolysosomal host-SARS-CoV-2 interface by the clinically licensed antidepressant fluoxetine (2020) (2)
Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection (2021) (2)
Signaling to Life and Death: Influenza Viruses and Intracellular Signal Transduction Cascades (2008) (2)
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination (2021) (2)
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly (2020) (2)
Team contact sports in times of the COVID-19 pandemic- a scientific concept for the Austrian football league (2020) (2)
Spontaneous onset of TNFα‐triggered colonic inflammation depends on functional T lymphocytes, S100A8/A9 alarmins, and MHC H‐2 haplotype (2020) (1)
The ubiquitination landscape of the influenza A virus polymerase (2022) (1)
Cystus052, a plant extract against seasonal and pandemic influenza virus (2009) (1)
β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling (2014) (1)
CYSTUS052, a new compound against seasonal and pandemic influenza virus (2009) (1)
Nonsense‐mediated mRNA decay does not restrict influenza A virus propagation (2021) (1)
Signaling Pathways Induced by Influenza Viruses (2009) (1)
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond (2022) (1)
Anti-viral approaches against influenza viruses (2006) (1)
Dynamic phospho-modification of viral proteins as a crucial regulatory layer of influenza A virus replication and innate immune responses (2021) (1)
Impact of Staphylococcus aureus Small Colony Variants on Human Lung Epithelial Cells with Subsequent Influenza Virus Infection (2020) (1)
HA-Membrane Accumulation Triggers RNP-Export 1 MEMBRANE ACCUMULATION OF INFLUENZA A VIRUS HEMAGGLUTININ TRIGGERS NUCLEAR EXPORT OF THE VIRAL GENOME VIA PKC α MEDIATED ACTIVATION OF ERK SIGNALING (2006) (1)
Influenza A viruses induce PI3-kinase activation by two interdependent mechanisms late in the infection cycle (2009) (1)
Rho GTPases are critical mediators of virus and dsRNA-induced activationof IRF-3 in the innate immune response to virus infections (2002) (1)
Early antiviral activity of CYSTUS052 against H5N1 influenza virus is more efficient compared to oseltamivir (2008) (1)
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier (2022) (1)
The NF-KappaB-Inhibitor SC75741 Efficiently Blocks Influenza Virus Propagation In Vitro and In Vivo Without the Tendency to Induce Resistant Virus Variant (2008) (1)
STAT Activation Protein Inhibits Glycoprotein 130-Dependent The Vesicular Stomatitis Virus Matrix (2001) (1)
Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles (2021) (1)
3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases (2022) (1)
Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection (2021) (1)
Corrigendum to “Pathogenicity of different PR8 influenza: A virus variants in mice is determined by both viral and host factors” [Virology 412 (2011) 36–45] (2014) (0)
EVALUATION OF CYTOTOXIC ACTIVITY OF CUCURBITACINS AND THEIR SEMISYNTHETIC DERIVATIVES (2014) (0)
Integrating evolutionary aspects into dual-use discussion: the cases of influenza virus and enterohemorrhagic Escherichia coli (2021) (0)
The ubiquitination landscape of the In uenza A Virus polymerase (2022) (0)
Interaction of PrPSc with the NF-kappaB signalling pathways (2005) (0)
Using acetylsalizilsäure for the prophylaxis and / or therapy of viral diseases (2004) (0)
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses (2022) (0)
Comparison of the antiviral potential of CYSTUS052 and oseltamivir against H5N1 Influenza virus (2008) (0)
Mechanisms of apoptosis suppression in Influenza A virus infected cells - the viral NS1 protein activates the PI3K to prevent premature cell death (2008) (0)
Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound (2018) (0)
Small spleen peptides prevent development of psoriatic arthritis via restoration of peripheral tolerance. (2021) (0)
NS-Segment of the Highly Pathogenic Avian Influenza Virus (HPAIV) A/goose/Guangdon/1/96 (H5N1) enhances replication efficiency of HPAIV A/FPV/Rostock/34 (H7N1) (2006) (0)
In vitro reassortment and adaptation of influenza A viruses circulating in swine (2020) (0)
Sequence of the nucleoprotein (NP) gene of the influenza Alanas acuta/Primorje/695/76 (H2N3) virus. (1991) (0)
in Primary Human Endothelial Cells Proinflammatory Gene Expression Program Distinct Signaling Pathways to Establish a Triggers Activation of Candida albicans (2007) (0)
transendothelial migration of phagocytes MRP8 and MRP14 control microtubule reorganization during (2013) (0)
Constitutive activation of the transcription Factor NF-KB results in impaired Borna disease virus infection of susceptible cells (2004) (0)
Screening and testing for a suitable untransfected cell line for SARS-CoV-2 studies (2020) (0)
Use of aspirin for the prophylaxis and / or therapy of viral diseases (2004) (0)
The different functions of PI3K during influenza virus replication (2011) (0)
Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA (2022) (0)
Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection (2021) (0)
Using a Acetylsalicylsäuresalzes for treating viral infections (2008) (0)
Molecular determinants of health and disease (2021) (0)
endothelial barrier dysfunction -induced lung injury and Staphylococcus aureus Atrial natriuretic peptide protects against (2015) (0)
Aspirin acts a an anti-influenza drug via inhibition of NF-kappaB- and caspase-dependent viral RNP export without the tendency to induce resistant virus variant (2005) (0)
Use of active substances for the prophylaxis and / or therapy of viral diseases (2001) (0)
The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza virus propagation via an unexpected hyperactivation of NF-kB (2009) (0)
The NF-kappaB-inhibitor SC75741 efficiently blocks influenza virus propagation in vitro and in vivo in a mouse infection model (2010) (0)
Antiviral action of a MEK-inhibitor on intra-nuclear replicating, negative-strand RNA viruses (2001) (0)
cells the monocyte chemoattractant protein-1 gene in primary endothelial dependent transcription of - B κ Multiple signaling pathways regulate NF- (2013) (0)
Use of a acetylsalicylsyresalt for the treatment of viral infections (2009) (0)
A pandemic in times of global tourism: superspreading and exportation of COVID-19 1 cases from a ski in Austria (2020) (0)
Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis (2023) (0)
In Vitro Models to Study Influenza Virus and Staphylococcus aureus Super-Infection on a Molecular Level. (2018) (0)
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases (2023) (0)
TRANSENDOTHELIAL MIGRATION OF PHAGOCYTES . running title : MRP 8 / MRP 14 complexes and migration of phagocytes (2004) (0)
Type I interferon-mediated signalling is inhibited upon influenza A virus and Staphylococcus aureus co-infection (2014) (0)
Role of PKCa in Influenza A virus induced Raf/MEK/ERK-signaling (2005) (0)
Article in press-uncorrected proof Identification and characterisation of novel Mss 4-binding Rab GTPases (2011) (0)
Highlight – Viruses and Signaling (2008) (0)
Use of substances that act as MEK inhibitor for the manufacture of a Arneimittels against DNA and RNA viruses (2000) (0)
Association of COVID-19 incidence with objectively and subjectively measured mental health proxies in the Austrian Football League: an epidemiological study (2021) (0)
Citizens, doctors, politicians - who´s an expert in times of COVID-19? A survey in Austria and Germany (2021) (0)
The binding of Mss4 to (cid:1) -integrin subunits regulates matrix metalloproteinase activation and ﬁbronectin remodeling (2007) (0)
Influenza virus replication and nuclear-cytoplasmic transport of the viral RNP complexes is impaired upon specific inhibition of the RAF/MEK/ERK signalling cascade (2000) (0)
The anti influenza viral activity of aspirin involves inhibitionof NF-KB dependent expression of proapoptotic factors (2004) (0)
A viral nucleoprotein functionally interacts with dhe Cdc2/cyclin B1 complex (2002) (0)
Demonstration of verotoxin production by Escherichia coli by a cell culture test and DNA hybridization applied to faeces from calves with diarrhoea. (1990) (0)
The polyphenol rich plant extract CYSTUS052 exerts potent antiviral activity against influenza- and rhinoviruses by preventing viral attachment to host cells (2010) (0)
A case report of COVID-19 monitoring in the Austrian professional football league (2021) (0)
Use of a salt of acetylsalicylic acid for the treatment of viral infections (2009) (0)
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients (2023) (0)
Specific Imbalanced Inflammatory Response Human Endothelial Cells Resulting in a H5N1 Virus Activates Signaling Pathways in (2010) (0)
Association of national COVID-19 cases with objectively and subjectively measured mental health proxies in the Austrian Football league – an epidemiological study (2021) (0)
Increase of mortality after influenza A virus infection in mice expressing active Raf kinase in the lung (2003) (0)
Local delivery of antiviral drugs into the respiratory system of influenza A virus infected mice (2003) (0)
Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells (2023) (0)
14 The function of MAP-kinase activated protein kinases in influenza A virus infection—Linking MAPK signalling to protein kinase R inhibition (2008) (0)
Zur Rechtmäßigkeit und Transparenz von Einziehungsanordnungen nach §16a Tierschutzgesetz (2014) (0)
Einfluss der Rückgrat-Liganden auf das Verhalten α-P,P und α-P,S-substituierter Wolfram-Alkinkomplexe (2020) (0)
Zoonosen im Netzwerk erforschen - Die Nationale Forschungsplattform für Zoonosen (2012) (0)
Nickelfreies grünes pigment (2015) (0)
Proteasom- oder ups-inhibitor zur behandlung von infektionen mit influenzaviren (2007) (0)
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination (2022) (0)
Einheit von Systemplanung und Wirtschaftlichkeitsrechnung für flexible Automatisierungslösungen (1991) (0)
Die Nationale Forschungsplattform für Zoonosen – ein Informations- und Servicenetzwerk (2009) (0)
Viral targeting of the interferon-beta inducing TANK-binding kinase(TBK)-1 (2005) (0)
Naturstoffe und pflanzliche Extrakte bei viralen Erkrankungen (2019) (0)
Verwendung von Acetylsalicylsäure zur Prophylaxe und/oder Therapie von Influenzavirus Infekten. (2004) (0)
Zoonosen : Die Gesundheit von Menschen und Tieren ist untrennbar verknüpft (2018) (0)
Wirt-orientierte Therapien bei Influenza – Was heißt das? (2014) (0)
Mitteilungen der DSTD-Gesellschaft (2011) (0)
Einfluss des Hohlraumgehaltes auf das Langzeitverhalten von Splittmastixasphaltdeckschichten (2007) (0)
Antivirale Aktivität von Ladania067, einem Extrakt aus Ribis nigri folium gegen Influenzaviren (2013) (0)
Prothetische Behandlungsmethoden und Behandlungsmittel an deutschen Hochschulen (2011) (0)
Capability of the viral NS1 proteins to bind to the cellular adaptor proteins Crk and CrkL determines sensitivity of influenza viruses to Crk/CrkL expression (2009) (0)
POTENTIELLE FOLSAEURE-ANTAGONISTEN 5. MITT. SYNTH. UND DIHYDROFOLAT-REDUKTASE-INHIBIERENDE WIRKUNG VON 4,6-SUBSTITUIERTEN 2-AMINO-5-ARYLAZOPYRIMIDINEN (1972) (0)
Beeinflussung der Zell-Zyklus Kontrolle in persistent Borna Disease Virus infizierten Zellen (2001) (0)
Forschen im Netzwerk – Zoonosen verstehen: Nationale Forschungsplattform für Zoonosen (2013) (0)
Substrate mit einer selbstreinigenden oberfläche, verfahren zu dessen herstellung und deren anwendung (2001) (0)
Zoonosen: Bekannte und neue Infektionskrankheiten - eine Herausforderung für die Forschung an der Schnittstelle von Human- und Veterinärmedizin (2011) (0)
Zur Rechtmäßigkeit und Transparenz von Einziehungsanordnungen nach §16a Tierschutzgesetz (2014) (0)
CYSTUS052, a polyphenol rich plant extract, exerts potent anti-influenza virus activity in cell culture by blocking viral attachment to host cells (2008) (0)
Spezifische Inhibition einer zellulären Kinase verhindert die Borna Disease Virus Replikation in Zellkultur (2000) (0)
Scheme for preparation of a novel semisynthetic derivative of cucurbitacin B (DACE). (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephan Ludwig?

Stephan Ludwig is affiliated with the following schools:

Stephan Ludwig's Academic­Influence.com Rankings

Stephan Ludwig's Degrees

Similar Degrees You Can Earn

Why Is Stephan Ludwig Influential?

Stephan Ludwig's Published Works

Published Works

What Schools Are Affiliated With Stephan Ludwig?

Stephan Ludwig's AcademicInfluence.com Rankings